Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

Notified -

Free Global Cities: A New Vision for Turning the Migration Crisis into an Opportunity

Notified -

Axi launches ‘Four Years’ campaign with Manchester City stars

Notified -

Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel

Notified -

Appian completes sale of MVV to Baiyin Nonferrous for US$420 million

Notified -

Mitolyn Reviews (NEW MEDICAL ALERT): Doctor Uncovers the Truth About This Bio-Energy Hack for Natural Weight Loss

Notified -

eXp Realty Debuts Co-Sponsor Program, Accelerating the Future of Collaborative Agent Growth

Notified -

General Fusion announces former Blue Origin CEO Bob Smith as new strategic advisor

Notified -

Freshworks Launches New Partner Program with Expanded Reseller and Services Offerings

Notified -

Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches

Notified -

Global Student Accommodation (GSA) Expands Relationship with Measurabl to Accelerate Sustainability Initiatives in Europe

Notified -

IceMOS Technology Closes $22 Million Series E Investment to Fund Launch of New Power Semiconductor Device Technology mSJMOS

Notified -